These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6980283)

  • 1. Absolute stereochemistry and dopaminergic activity of enantiomers of 2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine.
    Kaiser C; Dandridge PA; Garvey E; Hahn RA; Sarau HM; Setler PE; Bass LS; Clardy J
    J Med Chem; 1982 Jun; 25(6):697-703. PubMed ID: 6980283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic activity of substituted 6-chloro-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines.
    Pfeiffer FR; Wilson JW; Weinstock J; Kuo GY; Chambers PA; Holden KG; Hahn RA; Wardell JR; Tobia AJ; Setler PE; Sarau HM
    J Med Chem; 1982 Apr; 25(4):352-8. PubMed ID: 7069713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereoisomeric probes for the D1 dopamine receptor: synthesis and characterization of R-(+) and S-(-) enantiomers of 3-allyl-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine and its 6-bromo analogue.
    Neumeyer JL; Kula NS; Baldessarini RJ; Baindur N
    J Med Chem; 1992 Apr; 35(8):1466-71. PubMed ID: 1533424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, conformation, and dopaminergic activity of 5,6-ethano-bridged derivatives of selective dopaminergic 3-benzazepines.
    Weinstock J; Oh HJ; DeBrosse CW; Eggleston DS; Wise M; Flaim KE; Gessner GW; Sawyer JL; Kaiser C
    J Med Chem; 1987 Aug; 30(8):1303-8. PubMed ID: 2886663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (+/-)-3-Allyl-6-bromo-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3- benzazepin, a new high-affinity D1 dopamine receptor ligand: synthesis and structure-activity relationship.
    Neumeyer JL; Baindur N; Niznik HB; Guan HC; Seeman P
    J Med Chem; 1991 Dec; 34(12):3366-71. PubMed ID: 1684995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the enantiomers of SK&F 83566 as specific and stereoselective antagonists at the striatal D-1 dopamine receptor: comparisons with the D-2 enantioselectivity of Ro 22-1319.
    O'Boyle KM; Waddington JL
    Eur J Pharmacol; 1984 Oct; 106(1):219-20. PubMed ID: 6241567
    [No Abstract]   [Full Text] [Related]  

  • 7. Selective and stereospecific interactions of R-SK & F 38393 with [3H]piflutixol but not [3H]spiperone binding to striatal D1 and D2 dopamine receptors: comparisons with SCH 23390.
    O'Boyle KM; Waddington JL
    Eur J Pharmacol; 1984 Mar; 98(3-4):433-6. PubMed ID: 6144559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, resolution, absolute stereochemistry, and enantioselectivity of 3',4'-dihydroxynomifensine.
    Dandridge PA; Kaiser C; Brenner M; Gaitanopoulos D; Davis LD; Webb RL; Foley JJ; Sarau HM
    J Med Chem; 1984 Jan; 27(1):28-35. PubMed ID: 6317860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study on the contribution of the 1-phenyl substituent to the molecular electrostatic potentials of some benzazepines in relation to selective dopamine D-1 receptor activity.
    Pettersson I; Gundertofte K; Palm J; Liljefors T
    J Med Chem; 1992 Feb; 35(3):502-7. PubMed ID: 1531365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational analysis and structure-activity relationships of selective dopamine D-1 receptor agonists and antagonists of the benzazepine series.
    Pettersson I; Liljefors T; Bøgesø K
    J Med Chem; 1990 Aug; 33(8):2197-204. PubMed ID: 1973733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational analysis and molecular modeling of 1-phenyl-, 4-phenyl-, and 1-benzyl-1,2,3,4-tetrahydroisoquinolines as D1 dopamine receptor ligands.
    Charifson PS; Bowen JP; Wyrick SD; Hoffman AJ; Cory M; McPhail AT; Mailman RB
    J Med Chem; 1989 Sep; 32(9):2050-8. PubMed ID: 2527994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dihydrexidine, a novel selective high potency full dopamine D-1 receptor agonist.
    Lovenberg TW; Brewster WK; Mottola DM; Lee RC; Riggs RM; Nichols DE; Lewis MH; Mailman RB
    Eur J Pharmacol; 1989 Jul; 166(1):111-3. PubMed ID: 2572425
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis and dopamine receptor affinities of 6-amino-5,6,7,8-tetrahydroquinoline derivatives.
    Claudi F; Cingolani GM; Giorgioni G; Cattabeni F; Cimino M; Di Luca M
    Drug Des Deliv; 1989 Jun; 4(4):279-87. PubMed ID: 2570592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and renal vasodilator activity of some dopamine agonist 1-aryl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diols: halogen and methyl analogues of fenoldopam.
    Weinstock J; Ladd DL; Wilson JW; Brush CK; Yim NC; Gallagher G; McCarthy ME; Silvestri J; Sarau HM; Flaim KE
    J Med Chem; 1986 Nov; 29(11):2315-25. PubMed ID: 2878077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and receptor affinities of some conformationally restricted analogues of the dopamine D1 selective ligand (5R)-8-chloro-2,3,4,5-tetrahydro-3-methyl-5-phenyl- 1H-3-benzazepin-7-ol.
    Berger JG; Chang WK; Clader JW; Hou D; Chipkin RE; McPhail AT
    J Med Chem; 1989 Aug; 32(8):1913-21. PubMed ID: 2666667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural determinants of selective affinity for brain D-1 dopamine receptors within a series of 1-phenyl-1H-3-benzazepine analogues of SK&F 38393 and SCH 23390.
    O'Boyle KM; Waddington JL
    Eur J Pharmacol; 1985 Sep; 115(2-3):291-5. PubMed ID: 2866103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative activities of SCH 23390 and its analogs in three tests for D1/DA1 dopamine receptor antagonism.
    Barnett A; Ahn HS; Billard W; Gold EH; Kohli JD; Glock D; Goldberg LI
    Eur J Pharmacol; 1986 Sep; 128(3):249-53. PubMed ID: 2878816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Peripheral dopaminergic receptor agonists as potential drugs in diseases of the circulatory system].
    Kostowski W
    Pol Tyg Lek; 1985 Dec 23-30; 40(51-52):1448-51. PubMed ID: 2870482
    [No Abstract]   [Full Text] [Related]  

  • 19. New substituted 1-phenyl-3-benzazepine analogues of SK&F 38393 and N-methyl-thienopyridine analogues of dihydroxynomifensine with selective affinity for the D-1 dopamine receptor in human post-mortem brain.
    O'Boyle KM; Waddington JL
    Neuropharmacology; 1987 Dec; 26(12):1807-10. PubMed ID: 3501846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG; Walters JR
    Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.